Source Code: Your daily look at what matters in tech.

source-codesource codeauthorIssie LapowskyNoneWant your finger on the pulse of everything that's happening in tech? Sign up to get David Pierce's daily newsletter.64fd3cbe9f
×

Get access to Protocol

Your information will be used in accordance with our Privacy Policy

I’m already a subscriber
People

How to get the first COVID-19 vaccines to people who need it most

Whenever a vaccine is ready, mapping software will be crucial to helping states distribute it.

How to get the first COVID-19 vaccines to people who need it most

Esri wants to help governments route the first batch of vaccines to wherever they're needed most.

Photo: National Cancer Institute

Not everyone will be able to get the COVID-19 vaccine when it's ready. So even as companies like Pfizer and Moderna race to complete their clinical trials, governments are beginning to strategize how to distribute that very limited supply once it's ready. Este Geraghty, chief medical officer of the mapping software giant Esri, thinks her company's technology can help.

Before she joined the company, Geraghty specialized in informatics and statistics at the California Department of Health. That experience has come in handy these last seven months, as Esri has worked with state and local governments across the country to map the spread of COVID-19.

It's Esri's software that forms the backbone of Johns Hopkins University's vital COVID-19 dashboard and Esri's surveys that cities across the country have been using to map out the results of their contact tracing efforts.

Now, the 51-year-old company is looking ahead and helping governments think through how to ensure the people who need the vaccine the most will be able to receive it first. Geraghty spoke with Protocol about how Esri hopes to help.

This interview has been edited for clarity and brevity.

Why is mapping important to vaccine distribution?

We won't have all the vaccines ready at the same time with the ability to distribute it to everybody immediately. Given the manufacturing constraints and the differences in the vaccines that we think are going to be the ones to come out first, they require different kinds of facilities to administer them.

We think that the two furthest along are the Pfizer and the Moderna vaccines. The Pfizer vaccine requires storage at -70 degrees Celsius. That has significant implications for how you can transport it and where it can be stored. Probably only the largest hospitals and the larger pharmacies [can do it], but not everybody can store it at that level of cold storage. The Moderna on the other hand needs -20 degrees Celsius. That's really easy for just about anybody to create storage.

Now you have two different facilities with different capabilities. How do we get the two vaccines from these manufacturers to the different locations where they'll be distributed? With the Pfizer vaccine, you need to go straight to the point of dispensing, whether it's a hospital or pharmacy. It starts to get very geographic in the way you make these decisions.

When we get to state health departments working with the [Centers for Disease Control and Prevention], how do we make sure the vaccine goes to the right place in each state and locality? It gets back to identifying the right facilities capable of storing and distributing the two different kinds of vaccines. The next thing you want to do is identify and prioritize the clinical population. You've got to take care of healthcare workers first and other workers who are more exposed than the average population. These are the people who are most exposed coming into contact with a patient. If we don't take care of them and they become sick, then we lose our capacity, which is another issue. After that you get into populations that are more likely to have disease and die from the virus. Then there are things like congregate housing where people are living in nursing homes or prisons or university dormitories.

If we do this in a logical order, we have the best chance.

So a state or local government could use Esri to triangulate facilities that can store this thing and are closest to the highest density of congregate housing and health care workers?

You're getting the idea. You have a number of candidate facilities. Then the health department should be able to, with our software, evaluate the potential capacity of those sites and estimate a travel distance for the different phases of vaccination. When you get to a more general population, you're going to want 15- to 30-minute drive-times at the most to get to a vaccination venue.

It sounds like this would be pretty sparsely spread out throughout the country, not like going to your doctor's office and getting a shot in the arm.

That's right for the early phases. In those early phases, you'll pick the venues that can serve the largest part of your critical population. As we move toward broader vaccination, you can start to identify gaps where you have people who are a prioritized population and don't have a facility that's lined up or ready to distribute. That's where you can figure out where to put facilities to serve the largest population. You can also formulate other distribution methods. You can't put a facility in every place. A lot of people live way out in rural places, but still need vaccines. We've seen mobile vaccination teams go out. We can help route your mobile team so they can serve the biggest population efficiently.

Are you working with any of your government clients yet on this type of planning?

I'm not going to mention names, but I will tell you, it's a focus. We're dealing with a number of states, at least one city, and we've been having conversations at the national level as well. Every week it seems to get a little more in the forebrain of consciousness.

Whose decision will it ultimately be to figure out where the facilities should be located?

The decision is going to be somewhat joint as I understand it. The CDC is relying on the state public health department to come up with a plan. There's recognition that states across the country work in different ways with their local health authorities. If the health department wants a certain number of vaccines and has a distribution plan, it's expected the CDC will approve that plan, but they could override it.

Are there any other ways Esri plans to play a role in the vaccination distribution process?

Our software could be used to help with vaccine inventory and management. You need to be able to read the bar codes on the vaccines and keep track of your inventory and expiration dates and who got which vaccines. They both take two doses. If I got the first dose of the Pfizer vaccine, I cannot get the second dose of the Moderna vaccine. I need the same one. So we can help with that vaccine management system.

The other thing we're recommending to health departments is providing transparency and accurate communications. I think this whole process is complicated. I think people are going to want to know: When's it my turn? Where should I go to get a vaccine? And why is my turn not right now? You need to provide the information to help people understand the health departments are doing the right thing.

I shouldn't be conspiratorial, but it sounds like you'll have a window not just into where there are gaps, but whether there's corruption going on and are there vaccines being routed where there's not the most need. Will you have that kind of insight?

I think the system is set up pretty well so that shouldn't happen. What I fear more, and excuse my bias, is if people don't take a really geospatial approach to this, then they may end up not doing the prioritization in the most effective way. It may not be for lack of effort, but potentially lack of insight.

Does Elon Musk make Tesla tech?

Between the massive valuation and the self-driving software, Tesla isn't hard to sell as a tech company. But does that mean that, in 10 years, every car will be tech?

You know what's not tech and is a car company? Volkswagen.

Image: Tesla/Protocol

From disagreements about what "Autopilot" should mean and SolarCity lawsuits to space colonization and Boring Company tunnels, extremely online Tesla CEO Elon Musk and his company stay firmly in the news, giving us all plenty of opportunities to consider whether the company that made electric cars cool counts as tech.

The massive valuation definitely screams tech, as does the company's investment in self-driving software and battery development. But at the end of the day, this might not be enough to convince skeptics that Tesla is anything other than a car company that uses tech. It also raises questions about the role that timeliness plays in calling something tech. In a potential future where EVs are the norm and many run on Tesla's own software — which is well within the realm of possibility — will Tesla lose its claim to a tech pedigree?

Keep Reading Show less
Becca Evans
Becca Evans is a copy editor and producer at Protocol. Previously she edited Carrie Ann Conversations, a wellness and lifestyle publication founded by Carrie Ann Inaba. She's also written for STYLECASTER. Becca lives in Los Angeles.

As President of Alibaba Group, I am often asked, "What is Alibaba doing in the U.S.?"

In fact, most people are not aware we have a business in the U.S. because we are not a U.S. consumer-facing service that people use every day – nor do we want to be. Our consumers – nearly 900 million of them – are located in China.

Keep Reading Show less
J. Michael Evans
Michael Evans leads and executes Alibaba Group's international strategy for globalizing the company and expanding its businesses outside of China.
Protocol | Workplace

Apple isn’t the only tech company spooked by the delta variant

Spooked by rising cases of COVID-19, many tech companies delay their office reopening.

Apple and at least two other Silicon Valley companies have decided to delay their reopenings in response to rising COVID-19 case counts.

Photo: Luis Alvarez via Getty

Apple grabbed headlines this week when it told employees it would delay its office reopening until October or later. But the iPhone maker wasn't alone: At least two other Silicon Valley companies decided to delay their reopenings last week in response to rising COVID-19 case counts.

Both ServiceNow and Pure Storage opted to push back their September return-to-office dates last week, telling employees they can work remotely until at least the end of the year. Other companies may decide to exercise more caution given the current trends.

Keep Reading Show less
Allison Levitsky
Allison Levitsky is a reporter at Protocol covering workplace issues in tech. She previously covered big tech companies and the tech workforce for the Silicon Valley Business Journal. Allison grew up in the Bay Area and graduated from UC Berkeley.
Protocol | Workplace

Half of working parents have felt discriminated against during COVID

A new survey found that working parents at the VP level are more likely to say they've faced discrimination at work than their lower-level counterparts.

A new survey looks at discrimination faced by working parents during the pandemic.

Photo: d3sign/Getty Images

The toll COVID-19 has taken on working parents — particularly working moms — is, by now, well-documented. The impact for parents in low-wage jobs has been particularly devastating.

But a new survey, shared exclusively with Protocol, finds that among parents who kept their jobs through the pandemic, people who hold more senior positions are actually more likely to say they faced discrimination at work than their lower-level colleagues.

Keep Reading Show less
Issie Lapowsky

Issie Lapowsky ( @issielapowsky) is Protocol's chief correspondent, covering the intersection of technology, politics, and national affairs. She also oversees Protocol's fellowship program. Previously, she was a senior writer at Wired, where she covered the 2016 election and the Facebook beat in its aftermath. Prior to that, Issie worked as a staff writer for Inc. magazine, writing about small business and entrepreneurship. She has also worked as an on-air contributor for CBS News and taught a graduate-level course at New York University's Center for Publishing on how tech giants have affected publishing.

Protocol | Enterprise

Alphabet goes deep into industrial robotic software with Intrinsic

If it succeeds, the gambit could help support Google Cloud's lofty ambitions in the manufacturing sector.

Alphabet is aiming to make advanced robotic technology affordable to customers.

Photo: Getty Images

Alphabet launched a new division Friday called Intrinsic, which will focus on building software for industrial robots, per a blog post. The move plunges the tech giant deeper into a sector that's in the midst of a major wave of digitization.

The goal of Intrinsic is to "give industrial robots the ability to sense, learn, and automatically make adjustments as they're completing tasks, so they work in a wider range of settings and applications," CEO Wendy Tan-White wrote in the post.

Keep Reading Show less
Joe Williams

Joe Williams is a senior reporter at Protocol covering enterprise software, including industry giants like Salesforce, Microsoft, IBM and Oracle. He previously covered emerging technology for Business Insider. Joe can be reached at JWilliams@Protocol.com. To share information confidentially, he can also be contacted on a non-work device via Signal (+1-309-265-6120) or JPW53189@protonmail.com.

Latest Stories